What are the benefits of a transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass?
The benefits of a transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass include reducing blood loss, preventing transfusion reactions, and improving patient safety. Nuttall et al. (2001) conducted a randomized trial to evaluate the efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. They found that use of the algorithm reduced the average number of units of blood transfused, without increasing adverse effects or mortality. Royston and von Kier (2001) also reported reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass, which further supports the use of transfusion algorithms.  